A review of studies on diabetes mellitus and bladder cancer
返回论文页
|更新时间:2023-12-22
|
A review of studies on diabetes mellitus and bladder cancer
Journal of Chongqing Medical UniversityVol. 44, Issue 12, Pages: 1553(2019)
作者机构:
1. 重庆市南岸区中西医结合医院内科,重庆,400061
2. 重庆市中医院肝病科,重庆,400021
3. 武警重庆总队医院内分泌科,重庆,400061
作者简介:
基金信息:
DOI:
CLC:
Published:2019,
扫 描 看 全 文
Hu Changlun, Rao Chunyan, Luo Jian, et al. A review of studies on diabetes mellitus and bladder cancer. [J]. Journal of Chongqing Medical University 44(12):1553(2019)
DOI:
Hu Changlun, Rao Chunyan, Luo Jian, et al. A review of studies on diabetes mellitus and bladder cancer. [J]. Journal of Chongqing Medical University 44(12):1553(2019)DOI:
A review of studies on diabetes mellitus and bladder cancer
Nowadays,diabetes mellitus and bladder cancer are major public health problems in the world,which have a great impact on human health. Additionally,there are more and more patients with diabetes mellitus complicated with different cancers. A large number of studies have shown that there are some connections between bladder cancer and diabetes mellitus. Diabetes mellitus not only has many common risk factors with bladder cancer,but also may increase the incidence of bladder cancer and have a certain impact on its prognosis. Without doubt,there have been some studies holding different views. In addition,some antidiabetic drugs has certain correlation with bladder cancer. This article reviewed the relationship among diabetes mellitus,hypoglycemic drugs and bladder cancer,as well as the effect of diabetes mellitus on prognosis of bladder cancer.
Research progress on ultrasound elastography in lymph node evaluation
Value of inflammatory,pyroptosis,and ferroptosis biomarkers in the treatment and prognosis of bladder cancer
Correlation between serum KLF5 content and positive lymph node ratio and its predictive value for prognosis of patients with bladder cancer after radical operation
Value of inflammatory biomarkers in predicting the outcome of patients with muscle-invasive bladder cancer receiving different neoadjuvant treatment regimens
Related Author
Wang Zhen
Bai Jiayu
Li Peng
Jiao Guangyu
Pei Xiaming
Li Hong
Liang Yu
Xie Yu
Related Institution
Department of Respiratory and Critical Care Medicine,Shengjing Hospital of China Medical University
Department of Rheumatology and Immunology,The First Affiliated Hospital of China Medical University
Department of Urology,Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine,Central South University
Department of Urology,The Second Hospital,University of South China